Please check the individual session for location or broadcast availability.
Murali Chintagumpala, MBBS
Target Audience and Needs
Faculty, fellows, residents and other healthcare professionals involved in the management of children with central nervous system tumors need to be regularly updated with the recent advances and guidelines in the multidisciplinary management of these tumors. The tumor board aims to increase knowledge of the learners in these topic areas, and encourages learners to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.
Educational methods will include lectures, case presentations, and literature review.
At the conclusion of the sessions, the participants should be able to:
- Examine the importance of an integrated multi-disciplinary approach to the management of children with brain tumors and incorporate into clinical practice.
- Explain the rationale for specific tests for the diagnosis and management of pediatric brain tumors.
- Discuss the design of various phases of clinical trials, and compare the significance of early phase clinical trials versus phase 3 clinical trials.
- Evaluate the various therapeutic interventions for brain tumors, particularly with reference to neurosurgery, chemotherapy, and radiation therapy.
- Collect data to assess the process-related problem, devise a plan to improve the process, put it in practice, study the results, and implement the plan if there is improvement.
Participants may be asked to complete a session evaluation.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.